iOnctura
PrivateLast Round
Series B
Jun 20, 2024
Est. Valuation
$139.6M
Total Funding Raised
$111.26M
Company Overview
iOnctura is a biotechnology company focused on developing next-generation bio-molecules for the treatment of cancer and fibrosis through innovative therapeutics that target immunosuppression in the tumor microenvironment.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iOnctura Comps
Public and private peers based on sector, stage, and business model.
iOnctura Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 20, 2024 | ||||
| Grant | Dec 20, 2022 | ||||
| Debt | Sep 28, 2022 | ||||
| Series A Extension | Jul 14, 2020 | ||||
| Series A | Jan 23, 2020 | ||||
Seed | Jun 20, 2017 |
Key People
Founding team and executive leadership
iOnctura Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant, Series B |
| XGEN Venture | Series B |
| Syncona | Series B |
| Fongit | Debt |
| 3B FUTURE Health Fund | Series B, Series A Extension |
| M Ventures | Series A, Series B |
| VI Partners | Series B, Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 9, 2026
CEO to present at the 2026 J.P. Morgan Healthcare Conference.
- Jul 1, 2025
Collaborating with Dana-Farber Cancer Institute to expand US clinical trials.
iOnctura Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about iOnctura's valuation, stock price, and market status.
